Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

• Published in: The lancet respiratory medicine Vol. 10; no. 2; p. 167
• Main Authors: Toback, Seth, Galiza, Eva, Cosgrove, Catherine, Galloway, James, Goodman, Anna L, Swift, Pauline A, Rajaram, Sankarasubramanian, Graves-Jones, Alison, Edelman, Jonathan, Burns, Fiona, Minassian, Angela M, Cho, Iksung, Kumar, Lakshmi, Plested, Joyce S, Rivers, E Joy, Robertson, Andreana, Dubovsky, Filip, Glenn, Greg, Heath, Paul T
• Format: Journal Article
• Language: English
• Published: England 01.02.2022
• Subjects: Adolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Double-Blind Method; Humans; Immunogenicity, Vaccine; Influenza Vaccines - adverse effects; Middle Aged; SARS-CoV-2; Seasons; Young Adult

The safety and immunogenicity profile of COVID-19 vaccines when administered concomitantly with seasonal influenza vaccines have not yet been reported. We therefore aimed to report the results of a substudy within a phase 3 UK trial, by evaluating the safety, immunogenicity, and efficacy of NVX-CoV2...